NEVVI Medicare utilization intelligence
or

← back

Provider profile

DATTOLI, MICHAEL M.D.

Radiation Oncology · NPI 1235240664 · SARASOTA, FL

1
Groups
27
Codes · 2024
11,777
Disclosed services

DATTOLI, MICHAEL is a Radiation Oncology in SARASOTA, FL, a member of 1 medical group, who billed 27 distinct codes to Medicare Part B in 2024.

Groups: MICHAEL DATTOLI PLC (SARASOTA, FL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

11,777
disclosed services
27
codes billed to Medicare Part B
Prior year · CY2023 12,586 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0897 Injection, denosumab, 1 mg
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
G6017 Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment
77300 Calculation of radiation therapy dose
77290 Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved
76872 Ultrasound scan of pelvic region through rectum
93980 Complete ultrasound of penis artery and vein blood flow
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
77427 Radiation treatment management, 5 treatment sessions
77336 Continuing radiation therapy consultation per week
J3315 Injection, triptorelin pamoate, 3.75 mg
36415 Insertion of needle into vein for collection of blood sample
77338 Design and construction of radiation treatment device for high precision radiation therapy
71250 Ct scan of chest without contrast
74176 Ct scan of abdomen and pelvis without contrast
77014 Ct guidance for insertion of radiation therapy fields
77334 Design and construction of complex radiation treatment device
96372 Injection of drug or substance under skin or into muscle
77263 Complex radiation therapy planning
77470 Special radiation treatment
77293 Obtaining respiratory data needed to develop the optimal radiation treatment
77301 High precision radiation therapy planning
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
77078 Ct scan for measuring calcium and other minerals in bone
77295 3d radiation therapy planning
55874 Injection of biodegradable material next to prostate

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.